Abstract
An efficient synthesis of substituted pyrido[2,3-d]pyrimidines was carried out and evaluated for in vitro anticancer activity against five cancer cell lines, namely hepatic cancer (HepG-2), prostate cancer (PC-3), colon cancer (HCT-116), breast cancer (MCF-7), and lung cancer (A-549) cell lines. Regarding HepG-2, PC-3, HCT-116 cancer cell lines, 7-(4-chlorophenyl)-2-(3-methyl-5-oxo-2,3-dihydro-1H-pyrazol-1-yl)-5-(p-tolyl)- pyrido[2,3-d]pyrimidin-4(3H)-one (5a) exhibited strong, more potent anticancer (IC50: 0.3, 6.6 and 7 µM) relative to the standard doxorubicin (IC50: 0.6, 6.8 and 12.8 µM), respectively. Kinase inhibitory assessment of 5a showed promising inhibitory activity against three kinases namely PDGFR β, EGFR, and CDK4/cyclin D1 at two concentrations 50 and 100 µM in single measurements. Further, a molecular docking study for compound 5a was performed to verify the binding mode towards the EGFR and CDK4/cyclin D1 kinases.
References
Nov 1, 1985·Journal of Medicinal Chemistry·W A DennyL P Wakelin
Dec 16, 1983·Journal of Immunological Methods·T Mosmann
Aug 24, 1999·Pharmacology & Therapeutics·P Traxler, P Furet
Aug 28, 2002·The Journal of Biological Chemistry·Jennifer StamosCharles Eigenbrot
Aug 21, 2003·Cancer Treatment Reviews·Aoife M ShannonDeirdre Toomey
Nov 11, 2005·Molecular Biology of the Cell·Rene Rodriguez, Mark Meuth
Mar 7, 2006·Nature Reviews. Drug Discovery·Gergely SzakácsMichael M Gottesman
May 27, 2006·Science·Harold Varmus
Jun 27, 2008·Cellular and Molecular Life Sciences : CMLS·H Lage
Jul 9, 2009·Chemical Reviews·Paul D W Eckford, Frances J Sharom
Jun 29, 2010·European Journal of Medicinal Chemistry·Magda M F IsmailMohammad M M Hussein
Jul 20, 2010·Bioorganic & Medicinal Chemistry Letters·Liang-Wen ZhengJun-Ying Miao
Mar 25, 2011·European Journal of Medicinal Chemistry·Hala B El-Nassan
Mar 1, 2013·Archives of Pharmacal Research·Thoraya A Farghaly, Huwaida M E Hassaneen
Aug 1, 2013·European Journal of Medicinal Chemistry·Maria Teresa ConconiAdriana Chilin
Jun 24, 2014·European Journal of Medicinal Chemistry·Mohamed FaresRadwa Ahmed Eladwy
Sep 1, 2015·Cell Cycle·Solomon TadesseShudong Wang
Citations
Mar 21, 2019·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Mohamed El-NaggarMohamed A Al-Omar
Jul 30, 2019·Journal of Receptor and Signal Transduction Research·Maryam Tadayon, Zahra Garkani-Nejad
Mar 4, 2020·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Abd El-Galil E AmrElsayed A Elsayed
Jul 17, 2020·Journal of Enzyme Inhibition and Medicinal Chemistry·Ismail M M OthmanElsayed A Elsayed
Jul 10, 2019·Journal of Enzyme Inhibition and Medicinal Chemistry·Ismail M M OthmanAbd El-Galil E Amr
Sep 19, 2020·Chemical Biology & Drug Design·Pratibha Yadav, Kamal Shah
Jan 27, 2019·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Abd El-Galil E AmrMohamed M Abdallah
Jun 19, 2020·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Heba E HashemEman M Azmy
Nov 28, 2018·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Eman S NossierSalwa M El-Hallouty
Oct 30, 2019·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Eman M Mohi El-DeenEman S Nossier
Oct 18, 2020·Antibiotics·Eman M Mohi El-DeenMarwa F Ahmed
Jan 1, 2021·Nucleosides, Nucleotides & Nucleic Acids·Mosselhi A M MohamedAdil A Gobouri
Mar 17, 2021·ChemMedChem·Pule SeboletsweParvesh Singh
May 17, 2021·European Journal of Medicinal Chemistry·Adileh AyatiAlireza Foroumadi
Sep 2, 2021·Archiv der Pharmazie·Ahmed A GaberHamada S Abulkhair